Why Do Steroids Increase Risk Of Infection? Root Causes

Steroids calm inflammation by quieting the immune system. That same action is what raises infection risk. When you suppress the cells and signals that drive inflammation, you also blunt the ones that fight bacteria, viruses, and fungi. The result is a body that can be slower to detect and clear an infection — and sometimes less able to show the usual warning signs that something is wrong.

This article explains the root causes behind that trade-off. It covers which steroids are involved, what they do to immune cells, why dose and duration matter, and what the evidence does and does not show.

Which Steroids Are We Talking About?

The steroids that increase infection risk are glucocorticoids — prescription medications like prednisone, prednisolone, dexamethasone, and methylprednisolone. These are not the same as anabolic steroids used for muscle growth, and they are not the same as the hormone cortisol your body makes on its own.

Glucocorticoids are genuinely important medicines. They treat asthma flares, autoimmune conditions like rheumatoid arthritis and lupus, severe allergies, inflammatory bowel disease, and some cancers. They save lives in conditions such as severe asthma attacks and certain neurological emergencies. The infection risk is a real side effect of a real treatment, not a reason to avoid steroids when they are needed.

Anabolic steroids are a separate category. They are sometimes used illegally for muscle building. Their effects on the immune system are studied far less, and the evidence on infection risk is much weaker than for glucocorticoids. Most of what follows applies to prescription glucocorticoids.

Why Do Steroids Increase Risk Of Infection?

Glucocorticoids work by entering cells and changing how genes are read. They turn down the production of many inflammatory proteins and turn up others. This is why they are so effective against swelling, pain, and immune overactivity. The problem is that the same switch also dampens the body’s defenses.

Several things happen at once:

• White blood cells are less able to travel to infection sites. Neutrophils and other immune cells normally move toward chemical signals from damaged or infected tissue. Steroids reduce that movement.
• Immune cells function less effectively. Macrophages — the cells that engulf and destroy microbes — become less active. T cells that coordinate the response to viruses and some bacteria are suppressed.
• Inflammatory signals are reduced. Cytokines like interleukin-1 and tumor necrosis factor are key messengers that rally the immune response. Steroids lower their production.
• Fever and other warning signs may be masked. Because fever is partly driven by inflammation, steroids can blunt it. An infection may be harder to notice until it is more advanced.

None of these effects mean the immune system shuts off. It means the response is slower and less coordinated. For a mild infection, that may not matter much. For a serious one, the delay can be significant.

Does Dose And Duration Change The Risk?

Yes, and this is one of the clearest findings in the research. Infection risk rises with higher doses and longer courses. Short courses of steroids — for example, a few days for an asthma flare — carry a much lower risk than months of treatment for an autoimmune disease.

There is no single threshold below which risk disappears. Clinicians generally view risk as increasing with dose and time, not switching on at one specific number. This is why doctors aim for the lowest dose that controls the condition, and why they taper steroids rather than stopping suddenly.

It is also worth knowing that even steroid creams and inhaled steroids can carry some risk if used over large areas or for long periods, though the risk is generally lower than with pills because less of the drug reaches the whole body. This is a good example of how the route of delivery matters, not just the drug itself.

Which Infections Are Most Associated With Steroid Use?

Steroids raise risk across a wide range of infections, but some patterns are well documented.

Bacterial infections are a common concern, including pneumonia and skin infections. Opportunistic infections — those caused by organisms that rarely sicken healthy people — are more likely with higher doses and longer use. A well-known example is Pneumocystis jirovecii pneumonia, a fungal infection that can occur in people on prolonged high-dose steroids, even without other immune suppression.

Reactivation of latent infections is another important issue. If you have been exposed to tuberculosis or certain viruses in the past, steroids can allow a dormant infection to become active. This is why doctors sometimes test for tuberculosis before starting long-term steroid treatment.

Fungal infections also occur more often with prolonged use. These can be serious and are sometimes missed because the usual inflammatory signs are blunted.

The pattern is not random. Infections that a healthy immune system controls easily are the ones most likely to take hold when that system is suppressed.

How Do Doctors Manage The Risk?

Risk management is not about avoiding steroids when they are needed. It is about using them carefully.

Clinicians typically take several steps:

• Use the lowest effective dose for the shortest necessary time.
• Taper the dose rather than stopping abruptly, which also prevents other problems like adrenal insufficiency.
• Screen for latent infections such as tuberculosis before long-term treatment in some cases.
• Monitor for signs of infection, knowing that fever and inflammation may be less obvious.
• Consider preventive antibiotics or antifungals in specific high-risk situations, such as prolonged high-dose therapy.

If you take steroids and develop a fever, new cough, unusual fatigue, or a wound that is not healing, contact a clinician. Do not assume a lack of fever means there is no infection. This is a case where a suppressed warning sign can be misleading.

Are Inhaled And Topical Steroids Safer?

Generally, yes — but “safer” does not mean “risk-free.” Inhaled steroids for asthma and topical steroids for skin conditions deliver the drug mostly to the target area, so less reaches the rest of the body. The infection risk is lower than with oral steroids.

That said, inhaled steroids can increase the risk of certain respiratory infections, including oral thrush, and there is some evidence of a modest increase in pneumonia risk in people with COPD. Topical steroids used over large areas or under dressings can be absorbed enough to cause systemic effects.

The key point is that route of delivery changes how much drug reaches the whole body, and that changes the risk. It does not eliminate it.

What The Evidence Does And Does Not Show

The link between glucocorticoids and increased infection risk is well established. This is not a debated finding — it is a recognized effect of the drug class, documented across many conditions and settings.

What is less clear is the exact risk for any one person. Risk depends on dose, duration, the underlying condition, age, other medications, and individual factors. Two people on the same dose may face different risks.

It is also true that the underlying condition being treated often carries its own infection risk. Someone with severe rheumatoid arthritis or lupus may already be more prone to infections because of the disease itself. Separating the drug’s effect from the disease’s effect is not always simple, and researchers continue to study this.

What is clear is that steroids are not “immune boosters” or “immune suppressors” in a simple sense. They shift the immune response in specific ways. Understanding those ways is what allows doctors and patients to use them as safely as possible.